Showing results (221-230 of 252) with videos related to

Sort By:
Pageof 26
Cell Reports|December 19, 2019
Discrimination of Dormant and Active Hematopoietic Stem Cells by G0 Marker Reveals Dormancy Regulation by Cytoplasmic CalciumTsuyoshi Fukushima, Yosuke Tanaka, Fiona K Hamey, et al.
The Journal of Experimental Medicine|April 13, 2018
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformationReina Nagase, Daichi Inoue, Alessandro Pastore, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|December 16, 2014
The molecular basis of myeloid malignanciesToshio Kitamura, Daichi Inoue, Naoko Okochi-Watanabe, et al.
Cell Reports|September 15, 2023
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatmentTomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, et al.
The Journal of Biological Chemistry|January 24, 2018
The CD300e molecule in mice is an immune-activating receptorMasamichi Isobe, Kumi Izawa, Masahiro Sugiuchi, et al.
Blood|May 15, 2014
Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cellsFumio Nakahara, Jiro Kitaura, Tomoyuki Uchida, et al.
Nature Communications|January 13, 2022
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitorsYosuke Tanaka, Reina Takeda, Tsuyoshi Fukushima, et al.
Cell Reports|August 3, 2024
SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiationYu-Hsuan Chang, Keita Yamamoto, Takeshi Fujino, et al.
Leukemia|March 21, 2018
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignanciesDaichi Inoue, Takeshi Fujino, Paul Sheridan, et al.
Pageof 26